PRO337 polypeptides
View Patent ↗The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing, and immunoadhesions and antibodies to human neurotrimin or DNA43316.
1. An isolated polypeptide comprising:
(a) the amino acid sequence of the polypeptide of SEQ ID NO:523;
(b) the amino acid sequence of the polypeptide of SEQ ID NO:523, lacking its associated signal peptide; or
(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209487.
2. The isolated polypeptide of claim 1 comprising the amino acid sequence of the polypeptide of SEQ ID NO:523.
3. The isolated polypeptide of claim 1 comprising the amino acid sequence of the polypeptide of SEQ ID NO:523, lacking its associated signal peptide.
4. The isolated polypeptide of claim 1 comprising the amino acid sequence of the polypeptide encoded byte full-length coding sequence of the cDNA deposited under ATCC accession number 209487.
5. An isolated polypeptide comprising a polypeptide sequence having at least 95% amino acid sequence identity to:
(a) the amino acid sequence of the polypeptide of SEQ ID NO:523; or
(b) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209487,
wherein said polypeptide induces proliferation of rat utricular supporting cells.
6. An isolated polypeptide of claim 5 comprising a polypeptide sequence having at least 99% amino acid sequence identity to:
(a) the amino acid sequence of the polypeptide of SEQ ID NO:523;
(b) the amino acid sequence of the polypeptide of SEQ ID NO:523, lacking its associated signal peptide; or
(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209487,
wherein said polypeptide induces proliferation of rat utricular supporting cells.
7. A chimeric polypeptide comprising a polypeptide according to claim 5 fused to a heterologous polypeptide.
8. The chimeric polypeptide of claim 7 , wherein said heterologous polypeptide is an epitope tag or an Fc region of an immunoglobulin.